Antiproliferative effects of antisense oligonucleotides directed to the RNA of c-myc oncogene
- PMID: 1708128
- PMCID: PMC333736
- DOI: 10.1093/nar/19.4.945
Antiproliferative effects of antisense oligonucleotides directed to the RNA of c-myc oncogene
Abstract
Several groups have reported the use of antisense oligonucleotides to inhibit c-myc gene expression and study its biological role. However high concentrations of free oligonucleotides were generally needed. To lower their concentration and stabilize the antisense effect against c-myc, oligonucleotides were covalently linked to poly(L-lysine) and administered in ternary complexes formed with heparin (100 micrograms/ml). A sequence specific growth inhibition was observed at concentrations lower than 1 microM, while oligonucleotide-poly(L-lysine) conjugates alone were inefficient. Similar results occurred with other polyanionic compounds. Inhibition of proliferation was correlated to a reduction of c-myc protein and to a transient decrease in c-myc mRNA level. However, implication of RNase H in this process could not be demonstrated.
Similar articles
-
Antiproliferative effect of c-myc antisense phosphorothioate oligodeoxynucleotides in malignant glioma cells.Neurosurgery. 1997 Oct;41(4):908-15. doi: 10.1097/00006123-199710000-00027. Neurosurgery. 1997. PMID: 9316053
-
Oligonucleotide N3'-->P5' phosphoramidates as antisense agents.Nucleic Acids Res. 1996 Apr 15;24(8):1508-14. doi: 10.1093/nar/24.8.1508. Nucleic Acids Res. 1996. PMID: 8628685 Free PMC article.
-
Psoralen-modified clamp-forming antisense oligonucleotides reduce cellular c-Myc protein expression and B16-F0 proliferation.Nucleic Acids Res. 2001 Oct 1;29(19):4052-61. doi: 10.1093/nar/29.19.4052. Nucleic Acids Res. 2001. PMID: 11574688 Free PMC article.
-
Oligonucleotide N3'-->P5' phosphoramidates as potential therapeutic agents.Biochim Biophys Acta. 1999 Dec 10;1489(1):131-40. doi: 10.1016/s0167-4781(99)00151-7. Biochim Biophys Acta. 1999. PMID: 10807003 Review.
-
Rational design of sequence-specific oncogene inhibitors based on antisense and antigene oligonucleotides.Eur J Cancer. 1991;27(11):1466-71. doi: 10.1016/0277-5379(91)90033-a. Eur J Cancer. 1991. PMID: 1835863 Review.
Cited by
-
Cloning and functional expression of an Aplysia 5-HT receptor negatively coupled to adenylate cyclase.J Neurosci. 1998 Aug 1;18(15):5586-93. doi: 10.1523/JNEUROSCI.18-15-05586.1998. J Neurosci. 1998. PMID: 9671650 Free PMC article.
-
Effects of antisense DNA on POMC mRNA and ACTH levels in cultured human corticotroph adenoma cells.J Endocrinol Invest. 1994 Nov;17(10):817-9. doi: 10.1007/BF03347783. J Endocrinol Invest. 1994. PMID: 7699217
-
The role of endogenous interleukin-2 in proliferation of human carcinoma cell lines.Br J Cancer. 1999 Nov;81(5):822-31. doi: 10.1038/sj.bjc.6690770. Br J Cancer. 1999. PMID: 10555752 Free PMC article.
-
Antisense proliferating cell nuclear antigen oligonucleotides inhibit intimal hyperplasia in a rat carotid artery injury model.J Clin Invest. 1994 Jun;93(6):2351-6. doi: 10.1172/JCI117240. J Clin Invest. 1994. PMID: 7911126 Free PMC article.
-
Invasion by esophageal cancer cells: functional contribution of the urokinase plasminogen activation system, and inhibition by antisense oligonucleotides to urokinase or urokinase receptor.Clin Exp Metastasis. 1999 Feb;17(1):77-85. doi: 10.1023/a:1026470417680. Clin Exp Metastasis. 1999. PMID: 10390151
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources